Dr. Michael G. Indelicato is a rheumatologist in Peabody,Massachusetts. He graduated from New York College of Osteo Medicine of New York Institute of Technology in 2008 and has been in practice for 14 years.
Male
1154577476
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Injections of tendon sheath, ligament, or muscle membrane | 19.0 | 11.0 | 160.0 |
| Aspiration and/or injection of medium joint or joint capsule | 25.0 | 17.0 | 175.0 |
| Aspiration and/or injection of large joint or joint capsule | 130.0 | 73.0 | 220.0 |
| Insertion of needle into vein for collection of blood sample | 595.0 | 325.0 | 15.0 |
| Injection of anesthetic agent, collar bone nerve | 16.0 | 14.0 | 250.0 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 158.0 | 32.0 | 160.0 |
| Infusion of chemotherapy into a vein up to 1 hour | 414.0 | 62.0 | 400.0 |
| Infusion of chemotherapy into a vein | 183.0 | 28.0 | 125.0 |
| New patient office or other outpatient visit, typically 45 minutes | 85.0 | 85.0 | 375.0 |
| Established patient office or other outpatient visit, typically 15 minutes | 19.0 | 17.0 | 175.0 |
| Established patient office or other outpatient, visit typically 25 minutes | 634.0 | 360.0 | 250.0 |
| Established patient office or other outpatient, visit typically 40 minutes | 162.0 | 118.0 | 375.0 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11950.0 | 21.0 | 75.0 |
| Injection, denosumab, 1 mg | 2580.0 | 25.0 | 25.0 |
| Injection, golimumab, 1 mg, for intravenous use | 7551.0 | 12.0 | 40.0 |
| Injection, infliximab, excludes biosimilar, 10 mg | 6050.0 | 24.0 | 125.0 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 707.0 | 104.0 | 10.0 |
| Infusion, normal saline solution, 250 cc | 414.0 | 62.0 | 31.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.